Aidoc Overview
Aidoc is a pioneering force in clinical AI focusing on aiding and empowering healthcare teams to optimize patient treatment, resulting in improved economic value and clinical outcomes. Powered by Aidoc’s exclusive aiOS, the company analyzes and aggregates medical data that enables care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Aidoc AI is always on, running in the background to change the foreground.
Cumulative Funding Raised Over Time ($)
$7.0MApr 2017
$34.0MApr 2019
$100.0MJul 2021
$140.0MJul 2025
$250.0MJul 2025
$360.0MJun 2022
$390.0MNov 2023
$394.0MOct 2016
$414.0MSep 2020
Latest News
growth-positive
/PRNewswire/ -- Aidoc, the global leader in clinical AI, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
Aidoc, a leader in clinical AI, has received Breakthrough Device Designation from the FDA for its multi-triage solution, which flags numerous life-threatening medical conditions within a single workflow. This designation, a first for AI with such broad coverage, aims to expedite the review process for life-saving innovations. Aidocs CARE™ platform, integrated with aiOS™, is designed to enhance efficiency and care quality across health systems. The company has 18 FDA clearances and partnerships with Nvidia and AWS, with over $150 million committed to development. Aidocs solutions are deployed in over 1,600 hospitals globally, transforming patient outcomes through advanced AI technology.
FDA approved/pending approvalPartners
growth-positive
“The new technology means our mission is at hand - to support physicians in every patient encounter,” said Elad Walach, Co-Founder and CEO.
Israeli medtech startup Aidoc has received Breakthrough Device Designation from the U.S. FDA for its multi-triage solution, powered by the CARE foundation model. This designation allows simultaneous coverage of multiple pathologies in CT scans, enhancing clinical AI applications. Aidocs technology aims to support physicians by prioritizing high-risk cases and accelerating diagnoses, addressing delays in emergency departments. The company has 18 FDA clearances and assists in clinical decisions for over 45 million patients annually. In July 2025, Aidoc raised $150 million, backed by Nvidia, increasing its total funding to $370 million.
FDA approved/pending approvalInvestment
growth-positive
בתום תשע שנות שירות בתוכנית תלפיות היוקרתית, אלעד וולך החליט להקים חברה בתחום הרפואה ● יחד עם שני שותפים שהכיר בצבא, הוא עומד מאחורי מוצרים שמשמשים אלפי בתי חולים ברחבי העולם ● שיחה קצרה עם מנכ"ל Aidoc
Aidoc, co-founded by Elad Walach, has developed AI-based decision support systems for healthcare, particularly in radiology. The company has partnered with Nvidia and Amazon to advance its AI models, aiming to diagnose up to 90% of diseases within three years. Aidoc has raised approximately $370 million to date, with a recent $150 million investment to fund its foundational model. The companys products are used in over 2,000 hospitals worldwide, including nearly all hospitals in Israel. Aidoc employs around 500 people and generates tens of millions in revenue annually. The companys AI technology assists radiologists in making timely diagnostic decisions, enhancing patient care.
PartnersInvestmentCustomers
growth-positive
Aidoc raises $150M with Nvidia backing as AI pushes faster diagnosis | CTech
Aidoc, an AI company specializing in real-time clinical decision-making tools, has raised $150 million in a new funding round, bringing its total funding to $370 million. The round was co-led by General Catalyst and Square Peg, with NVentures, NVIDIAs investment arm, joining as a new investor. The funding will accelerate the development of Aidocs new Foundation Model, CARE, which supports two recently FDA-approved AI products. Aidocs platform, installed in thousands of hospitals worldwide, is expected to double its patient reach from 45 million to 100 million annually within three years. The company is expanding its platform to enable more AI companies to integrate, with seven already on board.
InvestmentCustomersPartners
growth-positive
/PRNewswire/ -- At HLTH Europe, Aidoc announced the release of BRIDGE, a new open-source framework developed to help healthcare organizations deploy AI safely,...
Aidoc has announced the release of BRIDGE, an open-source framework designed to help healthcare organizations deploy AI safely and effectively. Developed in collaboration with NVIDIA and other leading organizations, BRIDGE provides a comprehensive roadmap for hospitals to integrate AI solutions into clinical settings. The framework addresses technical, regulatory, and operational criteria necessary for AI deployment, aiming to unify fragmented processes across vendors and hospitals. It emphasizes trust-building, scalability, and system-level readiness, offering a shared structure for evaluating and implementing AI solutions. BRIDGE is publicly available and aims to evolve with advancements in clinical AI. Aidoc, known for its FDA-cleared clinical AI solutions, continues to set standards in healthcare AI deployment.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $374M |
| Last funding | $110M |
| Stage | D |
| Rounds | 9 |
| Investors | 13 |
Team Members
7
Employees: 500+
Web & Social Links
| Website | www.aidoc.com |
| Careers | Careers page |
Locations
Aminadav Street 3, Tel Aviv-Yafo, Israel
142 West 57th Street, New York, NY, USA
Photos & Videos
3 item(s)
Aidoc Business
Business models
B2B
Product stage
Released
Employees
500+
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportTarget Customer
Healthcare & Life SciencesHealthcareLaboratoriesProvidersCore Technology
Artificial IntelligenceComputer VisionMachine LearningTags (16)
cardiovasculardigital-healthcarediagnosticsimage-processingdoctorsdeep-learninghospitalshealth-informationcomputer-visionradiologyartificial-intelligenceneurologydecision-makingmachine-learningpulmonarydecision-supportGeographic Markets
AfricaBrazilUnited StatesIsraelEuropeAidoc Financials
$374M
Total funding
Undisclosed
Capital raised
$110M
Last funding
D
Funding stage
9
Total rounds
13
Investors
Cumulative Funding Raised Over Time ($)
$7.0MApr 2017
$34.0MApr 2019
$100.0MJul 2021
$140.0MJul 2025
$250.0MJul 2025
$360.0MJun 2022
$390.0MNov 2023
$394.0MOct 2016
$414.0MSep 2020
Private Equity Funding
Debt Financing
Jul 2025
$40M
Undisclosed Round
Jul 2025
$110M
General Catalyst (Lead), Square Peg (Lead)
,
Maor Investments, Nvidia, NVentures
Undisclosed Round
Nov 2023
$30M
D Round
Jun 2022
$110M
TCV (Lead)
,
Alpha Intelligence Capital, CDIB Capital, Maor Investments, Jibe Ventures
C Round
Jul 2021
$66M
General Catalyst (Lead)
,
Magma Venture Partners, Maor Investments, Sweetwood Ventures, Alpha Intelligence Capital, TLV Partners, Emerge, Square Peg
B Round
Sep 2020
$20M
Alpha Intelligence Capital, Maor Investments, Sweetwood Ventures
B Round
Apr 2019
$27M
Square Peg (Lead)
,
Emerge, TLV Partners, Magma Venture Partners
A Round
Apr 2017
$7M
TLV Partners, Emerge, Magma Venture Partners
Seed
Oct 2016
$4M
Emerge, Magma Venture Partners
Aidoc Lifecycle
Cumulative Funding Raised Over Time
$7.0MApr 2017
$34.0MApr 2019
$100.0MJul 2021
$140.0MJul 2025
$250.0MJul 2025
$360.0MJun 2022
$390.0MNov 2023
$394.0MOct 2016
$414.0MSep 2020
All Events
Debt Financing
Jul 2025
$40M
Undisclosed Round
Jul 2025
$110M
General Catalyst (Lead), Square Peg (Lead)
,
Maor Investments, Nvidia, NVentures
Undisclosed Round
Nov 2023
$30M
D Round
Jun 2022
$110M
TCV (Lead)
,
Alpha Intelligence Capital, CDIB Capital, Maor Investments, Jibe Ventures
C Round
Jul 2021
$66M
General Catalyst (Lead)
,
Magma Venture Partners, Maor Investments, Sweetwood Ventures, Alpha Intelligence Capital, TLV Partners, Emerge, Square Peg
B Round
Sep 2020
$20M
Alpha Intelligence Capital, Maor Investments, Sweetwood Ventures
B Round
Apr 2019
$27M
Square Peg (Lead)
,
Emerge, TLV Partners, Magma Venture Partners
A Round
Apr 2017
$7M
TLV Partners, Emerge, Magma Venture Partners
Seed
Oct 2016
$4M
Emerge, Magma Venture Partners
Aidoc News
57 articles
growth-positive
/PRNewswire/ -- Aidoc, the global leader in clinical AI, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
Aidoc, a leader in clinical AI, has received Breakthrough Device Designation from the FDA for its multi-triage solution, which flags numerous life-threatening medical conditions within a single workflow. This designation, a first for AI with such broad coverage, aims to expedite the review process for life-saving innovations. Aidocs CARE™ platform, integrated with aiOS™, is designed to enhance efficiency and care quality across health systems. The company has 18 FDA clearances and partnerships with Nvidia and AWS, with over $150 million committed to development. Aidocs solutions are deployed in over 1,600 hospitals globally, transforming patient outcomes through advanced AI technology.
FDA approved/pending approvalPartners
growth-positive
“The new technology means our mission is at hand - to support physicians in every patient encounter,” said Elad Walach, Co-Founder and CEO.
Israeli medtech startup Aidoc has received Breakthrough Device Designation from the U.S. FDA for its multi-triage solution, powered by the CARE foundation model. This designation allows simultaneous coverage of multiple pathologies in CT scans, enhancing clinical AI applications. Aidocs technology aims to support physicians by prioritizing high-risk cases and accelerating diagnoses, addressing delays in emergency departments. The company has 18 FDA clearances and assists in clinical decisions for over 45 million patients annually. In July 2025, Aidoc raised $150 million, backed by Nvidia, increasing its total funding to $370 million.
FDA approved/pending approvalInvestment
growth-positive
בתום תשע שנות שירות בתוכנית תלפיות היוקרתית, אלעד וולך החליט להקים חברה בתחום הרפואה ● יחד עם שני שותפים שהכיר בצבא, הוא עומד מאחורי מוצרים שמשמשים אלפי בתי חולים ברחבי העולם ● שיחה קצרה עם מנכ"ל Aidoc
Aidoc, co-founded by Elad Walach, has developed AI-based decision support systems for healthcare, particularly in radiology. The company has partnered with Nvidia and Amazon to advance its AI models, aiming to diagnose up to 90% of diseases within three years. Aidoc has raised approximately $370 million to date, with a recent $150 million investment to fund its foundational model. The companys products are used in over 2,000 hospitals worldwide, including nearly all hospitals in Israel. Aidoc employs around 500 people and generates tens of millions in revenue annually. The companys AI technology assists radiologists in making timely diagnostic decisions, enhancing patient care.
PartnersInvestmentCustomers
growth-positive
Aidoc raises $150M with Nvidia backing as AI pushes faster diagnosis | CTech
Aidoc, an AI company specializing in real-time clinical decision-making tools, has raised $150 million in a new funding round, bringing its total funding to $370 million. The round was co-led by General Catalyst and Square Peg, with NVentures, NVIDIAs investment arm, joining as a new investor. The funding will accelerate the development of Aidocs new Foundation Model, CARE, which supports two recently FDA-approved AI products. Aidocs platform, installed in thousands of hospitals worldwide, is expected to double its patient reach from 45 million to 100 million annually within three years. The company is expanding its platform to enable more AI companies to integrate, with seven already on board.
InvestmentCustomersPartners
growth-positive
/PRNewswire/ -- At HLTH Europe, Aidoc announced the release of BRIDGE, a new open-source framework developed to help healthcare organizations deploy AI safely,...
Aidoc has announced the release of BRIDGE, an open-source framework designed to help healthcare organizations deploy AI safely and effectively. Developed in collaboration with NVIDIA and other leading organizations, BRIDGE provides a comprehensive roadmap for hospitals to integrate AI solutions into clinical settings. The framework addresses technical, regulatory, and operational criteria necessary for AI deployment, aiming to unify fragmented processes across vendors and hospitals. It emphasizes trust-building, scalability, and system-level readiness, offering a shared structure for evaluating and implementing AI solutions. BRIDGE is publicly available and aims to evolve with advancements in clinical AI. Aidoc, known for its FDA-cleared clinical AI solutions, continues to set standards in healthcare AI deployment.
Partners
growth-positive
/PRNewswire/ -- Aidoc, a global leader in clinical AI, has secured a defining FDA clearance for a CADt AI solution powered by a foundation model — a major step...
Aidoc, a leader in clinical AI, has received FDA clearance for its CADt AI solution powered by the CARE1™ Foundation Model. This milestone highlights the transformative potential of foundation models in healthcare, enabling faster AI development and greater accuracy. Aidocs collaboration with Amazon Web Services (AWS) supports the enhancement of its aiOS™ platform and CARE™ Foundation Model technology. The clearance applies to Aidocs Rib Fractures triage solution, showcasing the scalability and clinical robustness of the CARE1™ model. Mercy, a healthcare organization, has deployed Aidocs tools, emphasizing the integration of AI into clinical practice. Aidocs advancements in AI technology aim to improve patient care and operational efficiency in healthcare systems.
Product StagePartnersFDA approved/pending approval
growth-positive
/PRNewswire/ -- Aidoc, the global leader in clinical AI, today announced a strategic collaboration agreement (SCA) to deliver next-generation healthcare AI...
Aidoc, a leader in clinical AI, has announced a strategic collaboration with Amazon Web Services (AWS) to enhance its healthcare AI solutions. This partnership aims to optimize Aidocs CARE™ Foundation Model, enabling real-time identification of critical conditions across various medical imaging modalities. The collaboration will leverage AWSs cloud capabilities to improve the scalability and accessibility of AI-driven healthcare solutions. Aidocs platform, aiOS™, will integrate with AWS to streamline deployment across hospitals globally, reducing IT complexity and enhancing patient care. Over the next year, Aidoc plans to expand its clinical AI capabilities and seek FDA clearance for new applications. This collaboration marks a significant step in advancing AI technology in healthcare.
Partners
growth-positive
/PRNewswire/ -- Aidoc, the global leader in clinical AI, has developed CARE1™ (Clinical AI Reasoning Engine, Version 1), a groundbreaking clinical-grade...
Aidoc, a leader in clinical AI, has submitted its first application based on the CARE1™ model for FDA review, marking a significant milestone in its multi-year investment in the CARE™ framework. CARE1™ is a clinical-grade AI model designed to enhance diagnostic accuracy and efficiency in healthcare. The model has been trained on millions of exams and aims to set a new standard for precision in clinical AI solutions. Aidocs submission for FDA 510(k) review involves a rib fractures triage module, showcasing the companys commitment to integrating foundation model technology into real-world clinical settings. This development is part of Aidocs broader strategy to transform AI in healthcare, emphasizing safety, validation, and meaningful clinical impact.
Investment
growth-positive
/PRNewswire/ -- Aidoc, a global pioneer in clinical AI solutions, today announced the expansion of its partnership with Integral Diagnostics (IDX), the leading...
Aidoc, a leader in clinical AI solutions, has expanded its partnership with Integral Diagnostics (IDX), a top provider of AI-driven medical imaging services in Australia and New Zealand. This collaboration leverages Aidocs aiOS™ platform to enhance radiology services, improving patient care and efficiency. Aidocs technology has processed over 600,000 cases across IDXs network, prioritizing critical findings and facilitating faster treatments. With the upcoming National Lung Cancer Screening Program in Australia, IDX is trialing a new algorithm within Aidocs platform to improve early detection of lung cancer. This partnership signifies a significant advancement in AI-powered radiology, aiming to improve patient outcomes and healthcare efficiency. Aidoc and IDX will be featured at the RANZCR conference in October 2024.
Partners
/PRNewswire/ -- Today, Aidoc, a leading healthcare AI provider, introduced seven new AI solutions to the European healthcare market. These additions mark a...
growth-positive
Aidoc's New AI Patient Management Technology Boosts Clinic Volumes and Elevates Patient Care
Aidoc, a clinical AI company, has unveiled its latest advancements in AI-powered patient management. The technology ensures that patients requiring follow-up for incidental or chronic conditions are accurately identified, captured, and monitored. Aidocs aiOS™ platform enhances the identification and awareness of various medical conditions and connects patients to specialty clinics. Yale New Haven Hospital deployed Aidocs AA patient management solution to enhance its aortic aneurysm management program, resulting in significant improvements in clinic volume, time to intervention, and aneurysm rupture rate.
CustomersPartners
growth-positive
Aidoc Unveils $30M Investment in Revolutionary Foundation Model for Imaging AI at RSNA 2023
Aidoc, a leading provider of clinical AI solutions, has announced a $30 million investment to create a comprehensive clinical AI foundation model. The model aims to enhance diagnostic precision and early detection of critical conditions. The company plans to use this model to develop a new category of products and experiences. Aidocs AI-powered solutions integrate into clinical workflows via its proprietary AI operating system, aiOS™. The company is already processing millions of patient scans each month and aims to expand its technology to new areas such as clinically accurate assessment of future clinical outcomes, simulation of future follow-up exams, and more.
Investment
growth-positive
University of Miami Health System to Maximize Patient Care with New Aidoc AI Technology
The University of Miami Health System (UHealth) has announced a system-wide deployment of AI technology from Aidoc, a pioneer in artificial intelligence. The technology will be used to identify suspected findings early in the care process, coordinate workflows and support continued care beyond diagnosis. Aidocs platform, the aiOS™, will flag abnormalities and expedite the triaging process for physicians, then facilitate seamless coordination among cross-specialty medical teams. The goal is to ensure patients receive timely and precise care when and where they need it most.
PartnersExpand
growth-positive
UZ Brussel PERT and Aidoc Pave the Way as First Hospital in Europe for Expedited Treatment of Pulmonary Embolism with AI
Aidoc, a clinical AI company, has announced a collaboration with the Pulmonary Embolism Response Team (PERT) at UZ Brussel, marking the first European hospital to use AI for cross-departmental care coordination. Aidocs AI system flags suspected cases of pulmonary embolism (PE) and sends an automatic alert to UZ Brussels PERT, allowing for quick decision-making and delivery of life-saving treatment. The AI platform has already been running at UZB, assessing all chest CT exams for PE and prioritising suspected positive cases in the radiology workflow.
PartnersExpand
growth-positive
Aidoc Expands its Partnership with GLEAMER to Enhance its Chest Imaging AI Suite
Aidoc, a leading provider of healthcare AI solutions, has announced an expanded partnership with GLEAMER, a European MedTech company. The partnership will integrate GLEAMERs ChestView AI solution for X-ray into Aidocs platform, enhancing its capabilities for chest imaging. The integration comes at a time when the UK government has unveiled a £21 million AI Diagnostic Fund to expedite AI integration into the NHS. The partnership signifies Aidocs commitment to substantial investment in the deployment of AI technology and its dedication to empowering healthcare professionals with advanced tools for earlier cancer diagnoses.
PartnersExpand
growth-positive
Aidoc and Mayo Clinic Platform Provide End-to-End AI Support to Maximize Patient Care
Aidoc, a pioneer in clinical AI technology, is partnering with Mayo Clinic Platform to improve healthcare by providing access to Aidocs AI technology and platform. Aidocs AI technology will serve as an orchestration engine for Mayo Clinic Platform, providing a unified operating system that operates in various clinical settings. The collaboration aims to improve clinical workflows, enhance patient outcomes and drive the evolution of healthcare through the power of AI. Aidocs solutions include FDA-cleared image algorithms, a mobile app for real-time notifications, and an AI operating system that addresses common challenges associated with AI implementation in healthcare settings.
Partners
growth-positive
Aidoc's AI Solution for Pulmonary Embolism Clinically Proven to Reduce Hospital Stay Duration and Improves Patient Access to Treatment
Aidocs AI solution for pulmonary embolism (PE) care has demonstrated significant clinical value in three studies conducted by the University of Texas Medical Branch, Jamaica Hospital Medical Center, and University of Chicago. The AI solution was found to reduce hospital length of stay, improve patient access, and accurately alert care teams of suspected PEs. The studies highlight the benefits of AI in managing acute PE, including patient outcome improvements. Aidocs AI solution has evolved from an algorithm to an enterprise-wide platform used by Pulmonary Embolism Response Teams across entire health systems.
CustomersPartners
growth-positive
Aidoc Introduces the First and Only AI-Powered Solution to Identify Suspected Posterior and Anterior Large and Medium Vessel Occlusions
Aidoc, a clinical AI company, has announced the launch of its Full Brain Solution. This AI technology will expand the anatomy analyzed to identify suspected strokes, allowing for the identification and care coordination of patients with medium vessel occlusions (MeVOs) as well as posterior and anterior large vessel occlusions (LVOs). The Full Brain Solution is the first and only AI technology to identify these conditions, enabling twice as many patients to receive faster access to life-saving therapy. The solution is delivered through Aidocs proprietary operating system (aiOS™) that integrates with existing IT infrastructure.
Customers
growth-positive
Clinical AI Pioneer Aidoc Partners with Ochsner Health to Transform Healthcare Delivery
Aidoc, a pioneer in clinical AI, has announced a partnership with Ochsner Health, a large healthcare system based in New Orleans. The partnership aims to leverage AI technology to improve patient care, support clinical teams, pioneer new solutions, and advance the quadruple aim in healthcare. Ochsners agreement with Aidoc includes imaging AI algorithms that identify acute abnormalities in patient scans and enable cross-specialty teams to coordinate care efficiently. The agreement also leverages Aidocs proprietary aiOS™, a solution that helps facilities overcome challenges common to AI implementation.
Partners
Neutral
U of L Health Partners with Aidoc to Upgrade Care Systems and Deliver Impact of AI to Physicians and Patients
The article mentions several companies involved in health technology and medical imaging, including Royal Philips, Nuance Communications, Inc., GE HealthCare, Hologic, Inc., and iCAD, Inc. These companies are developing and showcasing their latest advancements in artificial intelligence (AI) and medical imaging solutions. The article does not provide specific details about any new partnerships, investments, acquisitions, or other significant business developments related to these companies.
None
growth-positive
Israeli AI healthcare solutions co Aidoc raises $110m
Aidoc, an Israeli healthcare AI solutions company, has raised $110 million in a Series D financing round co-led by TCV and Alpha Intelligence Capital, with participation from CDIB Capital. This brings the total amount raised by the company to $250 million. The new funding will be used to expand the Aidoc AI Care Platform, which helps hospitals cope with physician and nursing shortages, rising supply costs, and a challenging economic environment. The platform provides deep, actionable insights derived from imaging data, electronic medical records and other clinical sources.
InvestmentExpand
growth-positive
Aidoc software receives FDA green light for flagging, triaging brain aneurysms
Aidoc, an AI healthcare company, has received its second FDA 510(k) clearance for its AI software that identifies and triages potential brain aneurysms in CT scans. This comes after the FDAs approval of Aidocs algorithm for detecting pneumothorax, a collapsed lung, on X-rays. The company has received nine 510(k) clearances in total, including for software that triages and notifies providers about various medical conditions. Aidocs CEO, Elad Walach, emphasized the need for a holistic approach to AI in healthcare. The company, founded in 2016, has raised around $140 million in total funding and plans to double its product offerings in 2022.
CustomersInvestment
growth-positive
Aidoc Receives FDA Clearance For X-Ray Solution To Detect A Collapsed Lung
Israeli AI-driven healthcare provider Aidoc has received FDA 510(k) clearance for its newly developed X-ray solution that detects cases of pneumothorax (collapsed lung) on X-rays. The solution uses a highly accurate algorithm to analyze X-ray images and flag early indicators of pneumothorax, allowing physicians to initiate treatment protocols much sooner. The software can run on all X-rays, including portable machines. Aidocs seven other FDA-cleared solutions are already implemented across US health systems.
CustomersExpand
Neutral
Aidoc: The international one-stop shop AI solution
The article discusses various studies and developments in the field of neuropsychology. It highlights the distinct brain activity in people with PTSD when recalling traumatic memories, a new perspective on Alzheimers symptoms, and the long-lasting effects of brain inflammation post-injury. The article also mentions a new technology, the Portable Neuromodulation Stimulator, that aids brain injury survivors in returning to work. Rafaat Rahmani, CEO of Lifescience Dynamics, discusses the resurgence in Alzheimers drug development. The article also touches on racial disparities in Alzheimers diagnosis in the US.
Customers
growth-positive
https://www.jpost.com/business-and-innovation/tech-and-start-ups/article-694495
Aidoc, a provider of artificial intelligence solutions for medical imaging, has partnered with Novant Health, a health network of over 1,800 physicians with 15 medical centers in the US. The partnership will see Novant Health incorporate Aidoc’s AI platform, which includes seven FDA-cleared solutions for triage and notification of patients with acute medical conditions. The aim is to improve patient outcomes and reduce emergency room and department stays. Novant Health will be using Aidoc’s solutions for intracranial hemorrhage, pulmonary embolism, incidental pulmonary embolism, c-spine fracture, and abdominal free air.
PartnersCustomers
growth-positive
Aidoc Releases the First 'AI OS' Unifying AI Across Enterprise Imaging to Address Technical Barriers of Using AI
Aidoc, a provider of AI solutions for medical imaging, has released the first AI Operating System (OS) for clinical use of multiple AI applications over a unified system. Alongside the new OS, Aidoc has added FDA-cleared solutions from five third-party AI companies to its existing seven FDA-cleared solutions, expanding its coverage across imaging subspecialties. The AI OS aims to solve technical barriers of using AI at scale by orchestrating a diverse set of AI solutions under one vendor-agnostic operating system. The companys AI solutions are currently used by 5,000 radiologists worldwide.
CustomersPartnersExpand
growth-positive
Aidoc teams up with ScreenPoint Medical on AI for mammograms
AI-enabled imaging company Aidoc is partnering with ScreenPoint Medical to integrate ScreenPoint’s tech into its platform. ScreenPoint’s algorithm assists radiologists in assessing 2D and 3D mammograms, which can help detect cancer earlier and reduce the time it takes to read a scan. Aidocs VP of business development, Tom Valent, said ScreenPoint Medical was the ideal partner for Aidoc in the womens health space. The partnership is seen as the next step in providing a practice-wide radiology tool.
Partners
growth-positive
Aidoc appoints Yuval Segev as its new Director of Cybersecurity
Aidoc, an AI-powered radiology platform, has appointed Yuval Segev as its new Director of Cyber Security. Segev, a former Director of Advanced Technology in the Israel National Cyber Directorate, will be responsible for the companys cyber defense and protection. The appointment comes at a time when Israel has been experiencing an increase in cyber threats targeting hospitals and health centers. Aidoc, founded in 2016, offers a solution to support clinicians with CT and radiology scans by identifying positive findings and prioritizing cases. The company has raised $140 million to date and its solutions are used in 600 medical centers globally.
Management Changes
growth-positive
Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism
Inari Medical, Inc. has announced a global partnership with Aidoc, an enterprise artificial intelligence (AI) solutions provider, to accelerate the adoption of AI for the detection and treatment of pulmonary embolism. The partnership aims to improve patient outcomes by quickly flagging studies with suspected pulmonary embolism findings. Aidocs AI-based activation solution facilitates rapid triage of patient scans with suspected positive findings for pulmonary embolism. Inaris CEO, Bill Hoffman, believes that AI offers a promising tool to ensure that all intermediate-high risk pulmonary embolism patients are identified and assessed for optimal treatment as quickly as possible.
Partners
growth-positive
Aidoc Raises $66 Million in Series C Round to Address Growing Demand for its Comprehensive AI Platform
Aidoc, an AI solutions provider for medical imaging, has raised $66 million in a Series C funding round led by General Catalyst, bringing its total funding to $140 million. The investment follows a surge in demand for Aidocs AI-driven solutions, including the largest clinical deployment of AI in healthcare through its partnership with Radiology Partners. Aidoc plans to use the new funding to expand its AI platform for medical imaging, taking it to the enterprise-grade level and empowering medical specialists worldwide.
InvestmentExpand
growth-positive
Aidoc and icometrix team up to transform stroke care coordination
Aidoc, a provider of AI solutions for medical imaging, and icometrix, a leader in imaging AI solutions for patients with neurological conditions, have announced a partnership to provide an AI-based Stroke suite for rapid triage of patients with suspected stroke. The suite will alert physicians, facilitating timely communication and speeding access to lifesaving treatment. The stroke suite includes Aidocs FDA-cleared AI stroke solution and icometrixs FDA-cleared icobrain-cva for the analysis of the tissue perfusion state on CT perfusion scans in patients with ischemic stroke.
Partners
growth-positive
Radiology Partners and Aidoc to use AI technology in radiology scans
Radiology Partners, a California-based leading radiology practice, has announced a partnership with Israeli startup Aidoc to provide AI solutions for improving medical imaging. Aidocs AI tools, which are currently deployed at over 500 leading medical centers worldwide, reduce assessment time and increase quality and efficiency by flagging acute anomalies in real-time. This partnership will allow Aidocs technology to be deployed at Radiology Partners facilities across the U.S. The companies also plan to develop new clinical programs and AI-based radiology services to further the impact of AI in clinical care.
PartnersExpand
growth-positive
Aidoc launches the first and only AI-based automated notification solution for high-risk pulmonary embolism patients
Aidoc, a provider of enterprise AI solutions, has launched an AI-based automated activation solution for rapid risk assessment and care coordination for high-risk pulmonary embolism (PE) patients. The solution, which includes Aidocs FDA-cleared solution for triage and notification of PE, automatically flags high-risk PE patients after a scan is performed and sends a notification to all relevant team members. The launch is part of an ongoing partnership with the Department of Radiology and Biomedical Imaging at Yale School of Medicine.
Partners
growth-positive
CEO of leading teleradiology provider joins Aidoc to support European expansion Alexander Böhmcker joins as VP Europe
Aidoc, a leading provider of AI solutions for medical imaging, has hired Alexander Böhmcker to head up the expansion of its European Division. Böhmcker, who was previously the CEO of Telemedicine Clinic (TMC), will work alongside Jeremy De Sy, Director of Sales Europe. Aidocs revenue quadrupled in 2020, with Europe now accounting for approximately one third of the companys current customers. The companys solutions have been implemented in University hospitals such as Antwerp, Basel, and Brussels, Unfallkrankenhaus Berlin, and leading Teleradiology companies TMC and Imadis.
Management ChangesExpand
growth-positive
Aidoc and Imbio Partner to Develop an AI Solution to Detect PE - Endovascular Today
Aidoc, a provider of enterprise artificial intelligence (AI) solutions, and Imbio, a provider of medical image analysis for pulmonary and cardiothoracic diseases, have announced a partnership to provide an end-to-end AI solution for pulmonary embolism (PE). The partnership aims to improve the efficiency and quality of PE detection and treatment. In October 2020, Aidoc announced FDA clearance for its triaging and notification algorithms for flagging and communicating incidental PE. The combined Aidoc and Imbio product is an investigational device that is limited by Federal law to investigational use.
Partners
6 biggest Israeli hospitals use Aidoc software to read CT scans, firm announces
growth-positive
Israelis Discover Brain Injuries in Record Time with New AI Tech
Tel Aviv-based Aidoc has developed artificial intelligence (AI) technology to help radiologists interpret medical images. The company, which was only founded in 2016, has already raised $60 million in investment and has seen its sales triple since the start of 2020. Aidocs products are already FDA approved and used in 400 medical centers on five continents, including Israel’s leading hospitals. The companys AI technology is used to quickly find serious abnormalities in X-Rays and CT scans including blood hemorrhaging, strokes, pulmonary embolism, and cervical spine fractures.
InvestmentCustomers
growth-positive
Aidoc granted AI 'industry-first' FDA clearance for triage of incidental pulmonary embolism
Aidoc Medical Ltd., a smart radiology company, has announced its sixth regulatory clearance from the U.S. Food and Drug Administration (FDA). This clearance allows the commercial use of its triaging and notification algorithms for flagging and communicating incidental pulmonary embolism. The solution provides an always-on safety net for unexpected cases. Aidoc, founded in 2016, provides AI tools to assist radiologists by detecting and pinpointing abnormalities with deep learning and AI algorithms that analyze medical images. In September, it raised $20 million in series B, bringing its total funding to $60 million.
CustomersInvestment
growth-positive
Radiology AI startup Aidoc raises additional $20 million for B round
Aidoc Medical Ltd., a Tel Aviv-based medtech startup, has raised an additional $20 million for its series B round, bringing the total to $47 million and the company’s total funding to date to $60 million. The round was led by Melbourne, Australia-based Square Peg Capital, with participation from Magma Ventures, TLV Partners, Emerge, Alpha Intelligence Capital and Maor Investments. Aidoc develops AI-based medical imaging software designed to quickly analyze medical scans and help doctors prioritize the most urgent cases. The company has tripled its revenue since the beginning of 2020 and its technology is used by 400 medical centers in five continents.
InvestmentExpand
growth-positive
FDA Greenlights Use of Aidoc's Imaging Technology to Detect Covid-19
The US Food and Drug Administration (FDA) has approved the use of technology developed by Tel Aviv-based Aidoc Medical Ltd. for detecting findings associated with Covid-19. Aidoc, founded in 2016, develops AI-based medical imaging software designed to quickly analyze medical scans, detect critical conditions, and predict possible complications. The technology is intended to help doctors prioritize the most urgent cases and expedite treatment. Aidocs system can help radiologists detect lung anomalies associated with Covid-19 in any CT scan that incidentally contains the lung or part of the lung.
Customers
growth-positive
FDA permits use of Aidoc's AI to detect 'incidental findings' associated with COVID-19
Aidoc, an AI solutions provider for radiologists, has received approval from the U.S. Food and Drug Administration for the use of its algorithms for adjunctive detection of findings associated with COVID-19. The models are not meant to replace traditional COVID-19 diagnostic tests, but they could be used to prioritize incidental CT findings tied with COVID-19 infections. Aidocs COVID-19 tool helps to isolate anomalies in CT studies containing the lung or part of the lung. The company claims that its products can reduce report turnaround times by up to 60.1%, and says that theyve so far analyzed over 1.2 million scans, detected over 360,000 signs of disease, and helped to prioritize more than 150,000 cases across over 300 inpatient and outpatient clinics, level 1 trauma centers, imaging centers, and teleradiology facilities.
CustomersExpand
https://www.oaoa.com/news/business/article_70fe9f7c-d40d-54ef-b5ff-b9e2aaa19f5e.html
Growth-Positive
LucidHealth Partners With Aidoc to Bring Advanced Radiology AI to Care Sites in the Midwest
LucidHealth, a physician-owned radiology company, has announced its partnership with AI vendor Aidoc to incorporate artificial intelligence into their radiology practice. The AI-powered diagnostic aid will help prioritize and expedite treatment to patients with critical, life-threatening conditions. LucidHealths Chief Medical Officer, Mark Alfonso, stated that the integration of Aidocs AI-powered alerting system with their proprietary workflow software, RadAssist, will enable them to prioritize patients with the most urgent conditions. The partnership will enhance patient care for the most critical cases across the Midwest.
PartnersCustomers
growth-positive
Medical Imaging Startup Aidoc Gets FDA Clearance For AI Solution To Spot Stroke
Israeli startup Aidoc, which develops AI-powered software to analyse medical images, has received clearance from the US Food and Drug Administration (FDA) for its AI solution for flagging large-vessel occlusion (LVO) in head CTA scans. This is the fourth FDA-cleared AI package from Aidoc, which can now provide a comprehensive AI package for the identification and triage of both ischemic and hemorrhagic stroke in CTs. The companys solutions are in use in over 300 medical centres worldwide. Aidoc raised $27m in a Series B round in April 2019, and has raised some $40m to date.
InvestmentCustomers
growth-positive
Aidoc's Pulmonary Embolism Solution Granted FDA Clearance
Aidoc, an AI solutions provider for radiologists, has received clearance from the US Food and Drug Administration for its pulmonary embolism solution. The platform helps radiologists identify cases of pulmonary embolism in chest CT scans, allowing them to prioritise time-sensitive and potentially life-threatening cases. Aidoc claims its solutions reduce the time from scan to diagnosis from hours to under five minutes. The approval comes weeks after Aidoc raised $27 million in funding to expand its software suite.
CustomersInvestment
growth-positive
Israeli AI medical imaging co Aidoc raises $27m
Israeli artificial intelligence (AI) medical imaging company Aidoc has raised $27 million in a Series B funding round led by Square Peg Capital. The funds will be used to further develop Aidocs technology and marketing team to support the high market demand for its products. The company has announced that it has analyzed its millionth patients CT scan in real-time. Aidocs FDA-cleared and CE-marked solutions support and enhance the impact of radiologist diagnostic power, helping them expedite patient treatment and improve quality of care.
InvestmentExpand
growth-positive
Ghent Hospital AZ Maria Middelares to Use Aidoc AI to Speed Radiology Workflow
Belgian hospital AZ Maria Middelares is partnering with AI company Aidoc to introduce AI into its radiology practice. The AI will be used to detect specific critical conditions in head and cervical spine CT exams. This makes AZ Maria Middelares the first private hospital in Europe to purchase and implement a deep learning solution for use in its radiology workflow. Aidocs AI solution will analyze medical images upon acquisition and prioritize the radiologists workload to ensure that the most critical cases are diagnosed and treated first.
Partners
Growth-Positive
Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool
The article discusses Aidocs solution that flags and prioritizes pulmonary embolisms found in CT pulmonary angiograms. This solution is beneficial for both patients and healthcare providers. The article also mentions other health technology companies and their recent developments, including Royal Philips, Nuance Communications, Inc., and Hologic, Inc.
Customers
growth-positive
Belgium hospital implements Aidoc's AI neuro solution
Antwerp University Hospital in Belgium has implemented Aidocs AI neurology solution to triage and detect subdural hemorrhages in the brain and C-spine fractures. The solution, which has been integrated into the hospitals GE Healthcare PACS, will identify and flag time-sensitive and life-threatening conditions in CT scans to ensure that radiologists look at those images right away. The hospital performs 160,000 imaging procedures per year. The solution received FDA clearance in August and was already commercialized outside the U.S. since December 2017.
CustomersPartners
growth-positive
Aidoc Partners With the ACR Data Science Institute on Industry-first AI Validation Process
Aidoc, a provider of AI solutions for radiologists, has announced that its solution for automatic flagging and prioritization of critical CT cases is now in full use at the University of Rochester Medicine. The solution is integrated with Nuances PowerScribe Workflow Orchestration platform, which improves disease detection, diagnosis, follow-up and treatment. The partnership allows the two companies to contribute to the American College of Radiology (ACR) DSI ASSESS-AI registry, a framework for post-market surveillance and continuous validation of AI solutions in real clinical settings.
CustomersPartners
growth-positive
Aidoc and SaferMD Team Up to Close the Loop of AI Radiology Medicare Payments
AI radiology solutions provider, Aidoc, has announced a partnership with SaferMD to provide a solution that uses AI to improve clinical performance and reward radiologists with higher scores in the Medicare Merit-Based Incentive Payments System (MIPS). The partnership will allow healthcare providers to earn positive payments if they demonstrate high-quality, efficient care. The combined solution of Aidoc and SaferMD will automatically generate the data needed to report MIPS and show the value of AI-based imaging analysis.
Partners
Israeli brain scan-reading AI-based software gets thumbs up from FDA, Time
Growth-Positive
Aidoc Ramps Up Distribution of AI Solution for Radiology, Expands in the United States and Europe
Aidoc, a provider of artificial intelligence solutions for radiologists, is expanding to meet customer demand in the US and Europe. This follows the first FDA approval of Aidocs AI-driven radiology triage solution. The company has appointed Tom Shearer as its first North American Director of Sales and Strategy, and Jeremy De Sy as Sales Manager for its European operation. Aidocs technology prioritizes cases for radiologists, ensuring that patients with the most urgent conditions are diagnosed first.
ExpandManagement Changes
growth-positive
Aidoc gains FDA clearance for AI solution that detects suspected ICH cases, alerts radiologists
Aidoc, a medical imaging company based in Tel-Aviv, Israel, has received FDA clearance for its brain solution that assists radiologists in identifying acute intracranial hemorrhage (ICH) cases using artificial intelligence. The solution, which is the first deep learning solution in the market that directly assists radiologists with workflow triage, examines head CT exams immediately after the patient is scanned and alerts the radiologist when a potential ICH is detected. The software has demonstrated its potential to significantly reduce report turnaround time and increase the radiologist’s confidence.
Customers
growth-positive
Aidoc harnesses deep learning to improve the radiologist's workflow
Aidoc, an Israeli startup, is using artificial intelligence and deep learning to assist radiologists. The companys technology runs algorithms on incoming scans as they arrive at the healthcare organization, helping to flag specific cases earlier on for better prioritization. Aidoc has already closed two funding rounds, raising $3 million in 2016 and $7 million earlier this year. The company has received CE marking for its head and neck imaging solution, allowing it to be commercialized in Europe. In the US, Aidocs solution was assessed by Cedars-Sinai Medical Center, yielding positive results. The company hopes to gain FDA approval and become fully commercial in the US next year.
CustomersInvestment
growth-positive
Aidoc Receives CE Mark for First Commercial Deep Learning Solution Streamlining Head and Neck Imaging for Radiologists
Aidoc, an AI startup that uses deep learning to enhance radiologists workflow, has received CE (Conformité Européenne) marking for its head and neck deep learning medical imaging solution. This allows for the commercialisation of Aidocs solution in Europe. The technology can detect abnormalities in imaging of the head and neck, which can be crucial in trauma cases. The solution can also help radiologists prioritise readings, reducing time to decision. Aidocs CEO, Elad Walach, said the technology could have a monumental impact on radiology workflow, making treatment more cost-effective.
CustomersExpand
growth-positive
AIDoc Medical raises $7M to bring AI to medical imaging analysis
AIdoc Medical, an Israeli start-up that uses artificial intelligence (AI) to detect abnormalities in medical scans, has raised $7m in a funding round led by TLV Partners. The companys technology is designed to fit into a radiologists existing workflow and help make their job more efficient. The funds will be used to expand its core R&D team, customer success, and marketing teams both in the U.S. and in Israel. AIdocs CEO, Elad Walach, said the companys main competitor is IBM Watson Health.
InvestmentExpand
Aidoc Team
Employee Info
| Employees (range) | 500+ |
| Exact count | 519 |
| Team members | 7 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 10 classification IDs that could be used for matching.
Aidoc Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 515395184 |
| Crunchbase | aidoc |
| Phone | +972737946875 |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-02-05T00:00:00.000Z |
| Created | 2015-12-22T00:00:00.000Z |
| Claimed | Yes |